SCHEMBL6280176

SCHEMBL6280176

Cn1ccc2c(ncn2-c2ccc(F)c(-c3cccnc3)c2)c1=O

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CTSD P07339 1/20 0.40
▸ BACE1 P56817 1/20 0.40
▸ BACE2 Q9Y5Z0 1/20 0.40
▸ GRIN1 Q05586 8/20 0.39
▸ GRIN2B Q13224 8/20 0.39
▸ GABRA1 P14867 3/20 0.38
▸ GABRG2 P18507 3/20 0.38
▸ GABRB3 P28472 3/20 0.38
▸ GABRA5 P31644 3/20 0.38
▸ GABRA3 P34903 3/20 0.38
▸ GABRA2 P47869 2/20 0.38
▸ CYP2E1 P05181 1/20 0.38
▸ CYP2A6 P11509 1/20 0.38
▸ CYP2C9 P11712 1/20 0.38
▸ CYP2B6 P20813 1/20 0.38
▸ CYP2C19 P33261 1/20 0.38
▸ MET P08581 2/20 0.37
▸ CYP11B2 P19099 2/20 0.36
▸ GRM1 Q13255 1/20 0.35
▸ CYP11B1 P15538 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6279750 0.87 GRIN1 (0.39) GRIN1GRIN2BGRM1
SCHEMBL6285997 0.81 GRM1 (0.40) GRIN1GRIN2BGABRA1GABRG2GABRB3
SCHEMBL6284962 0.77 MIF (0.35) GRIN1GRIN2BCYP11B2GRM1
SCHEMBL6283855 0.74 GABRA1 (0.44) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL6284455 0.69 GABRA1 (0.56) GABRA1GABRG2GABRB3GABRA5GABRA3
SCHEMBL2651076 0.69 CYP3A4 (0.54) CYP2A6CYP2C19CYP11B2CYP11B1ABL1
SCHEMBL30445600 0.66 CYP2A6 (0.49) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL30577111 0.65 CYP2A6 (0.60) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL27249454 0.65 CYP17A1 (0.47) CYP2E1CYP2A6CYP2C9CYP2B6CYP2C19
SCHEMBL2665898 0.64 CYP2A6 (0.51) GABRA1GABRG2GABRB3GABRA5GABRA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6887885-B2 Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands MERCK SHARP & DOHME LTD 2005-05-03 — — US claimed
US-6887885-B2 Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands MERCK SHARP & DOHME LTD 2005-05-03 — — US disclosed
US-20040132767-A1 Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands MERCK SHARP & DOHME LTD. (GB) 2004-07-08 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040132767-A1 Imidazo[4,5-c]pyridin-4-one analogues as GABAA receptor ligands GABRA1, GABRA2, GABRA3 CTSD 4752/4885BACE1 866/4885BACE2 1485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback